Duyuru • Jul 01
McKesson Corporation Announces Management Changes, Effective August 1, 2026 McKesson Corporation announced that on June 29, 2026, Thomas L. Rodgers, the company's Executive Vice President, Chief Strategy and Business Development Officer and a named executive officer, gave notice of his intention to retire from that role. His last day of employment will be August 1, 2026. To support an orderly transition, the company appointed Ramesh Srinivasan as Executive Vice President, Chief Strategy Officer, effective on August 1, 2026. Duyuru • Jun 25
McKesson Corporation to Report Q1, 2027 Results on Aug 05, 2026 McKesson Corporation announced that they will report Q1, 2027 results on Aug 05, 2026 Duyuru • Jun 15
McKesson Corporation, Annual General Meeting, Jul 22, 2026 McKesson Corporation, Annual General Meeting, Jul 22, 2026. Upcoming Dividend • May 23
Upcoming dividend of US$0.82 per share Eligible shareholders must have bought the stock before 29 May 2026. Payment date: 01 July 2026. Payout ratio is a comfortable 8.2% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.5%). Lower than average of industry peers (2.6%). Reported Earnings • May 08
Full year 2026 earnings released: EPS: US$38.53 (vs US$25.86 in FY 2025) Full year 2026 results: EPS: US$38.53 (up from US$25.86 in FY 2025). Revenue: US$403.4b (up 12% from FY 2025). Net income: US$4.76b (up 45% from FY 2025). Profit margin: 1.2% (up from 0.9% in FY 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe. Declared Dividend • May 04
Dividend of US$0.82 announced Shareholders will receive a dividend of US$0.82. Ex-date: 29th May 2026 Payment date: 1st July 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 9%. Cash payout ratio: 4%. Duyuru • Apr 23
McKesson Corporation Declares Regular Dividend, Payable on July 1, 2026 The Board of Directors of McKesson Corporation declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026. Duyuru • Apr 22
Apollo Global Management, Inc. (NYSE:APO) entered into a definitive agreement to acquire 13% stake in McKesson Medical-Surgical Inc. from McKesson Corporation (NYSE:MCK) for $1.3 billion. Apollo Global Management, Inc. (NYSE:APO) entered into a definitive agreement to acquire 13% stake in McKesson Medical-Surgical Inc. from McKesson Corporation (NYSE:MCK) for $1.3 billion on April 20, 2026. The consideration consists of convertible preferred equity of Apollo Global Management, Inc. having a value of $1.25 billion to be issued for common equity of McKesson Medical-Surgical Inc. Following the acquisition, McKesson will retain operating control and majority ownership of MMS and consolidate the results for financial reporting.
The transaction is subject to regulatory approvals and customary closing conditions.
Tracey Zaccone, Michael Anastasio, Salvatore Vanchieri, and Julian Azran of Latham & Watkins LLP acted as legal advisor for Apollo Global Management, Inc. Alan F. Denenberg and Michael Diz, Jason Bassetti, Patrick E. Sigmon, Liang Zhang, Adam Kaminsky, Frank Azzopardi, and Suzanne Munck af Rosenschold of Davis Polk & Wardwell LLP acted as legal advisor for McKesson Corporation. New Risk • Mar 27
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Italian stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.6% average weekly change). Minor Risk Negative equity (-US$99m). Duyuru • Mar 06
McKesson Corporation to Report Q4, 2026 Results on May 07, 2026 McKesson Corporation announced that they will report Q4, 2026 results After-Market on May 07, 2026 Upcoming Dividend • Feb 20
Upcoming dividend of US$0.82 per share Eligible shareholders must have bought the stock before 27 February 2026. Payment date: 01 April 2026. Payout ratio is a comfortable 8.8% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.6%). Lower than average of industry peers (2.2%). New Risk • Feb 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Negative equity (-US$99m). Share price has been volatile over the past 3 months (5.2% average weekly change). Reported Earnings • Feb 05
Third quarter 2026 earnings released: EPS: US$9.63 (vs US$6.98 in 3Q 2025) Third quarter 2026 results: EPS: US$9.63 (up from US$6.98 in 3Q 2025). Revenue: US$106.2b (up 11% from 3Q 2025). Net income: US$1.19b (up 35% from 3Q 2025). Profit margin: 1.1% (up from 0.9% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Healthcare industry in Europe. Declared Dividend • Feb 01
Dividend of US$0.82 announced Shareholders will receive a dividend of US$0.82. Ex-date: 27th February 2026 Payment date: 1st April 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 9%. Cash payout ratio: 7%. Duyuru • Jan 28
Mckesson Corporation Declares Dividend, Payable on April 1, 2026 McKesson Corporation declares regular dividend of 82 cents per share of common stock. The dividend will be payable on Aril 1, 2026 to shareholders of record on March 2, 2026. Duyuru • Dec 22
McKesson Corporation to Report Q3, 2026 Results on Feb 04, 2026 McKesson Corporation announced that they will report Q3, 2026 results After-Market on Feb 04, 2026 Upcoming Dividend • Nov 21
Upcoming dividend of US$0.82 per share Eligible shareholders must have bought the stock before 28 November 2025. Payment date: 02 January 2026. Payout ratio is a comfortable 9.1% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.9%). Lower than average of industry peers (2.4%). Reported Earnings • Nov 06
Second quarter 2026 earnings released: EPS: US$8.95 (vs US$1.87 in 2Q 2025) Second quarter 2026 results: EPS: US$8.95 (up from US$1.87 in 2Q 2025). Revenue: US$103.2b (up 10% from 2Q 2025). Net income: US$1.11b (up 361% from 2Q 2025). Profit margin: 1.1% (up from 0.3% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe. Declared Dividend • Nov 03
Dividend of US$0.82 announced Shareholders will receive a dividend of US$0.82. Ex-date: 28th November 2025 Payment date: 2nd January 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 11%. Cash payout ratio: 7%. Duyuru • Oct 30
McKesson Corporation Declares Quarterly Dividend on Common Stock, Payable on January 2, 2026 The Board of Directors of McKesson Corporation declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on January 2, 2026 to shareholders of record on December 1, 2025. Duyuru • Sep 23
McKesson Corporation to Report Q2, 2026 Results on Nov 05, 2025 McKesson Corporation announced that they will report Q2, 2026 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025 Reported Earnings • Aug 07
First quarter 2026 earnings released: EPS: US$6.28 (vs US$7.05 in 1Q 2025) First quarter 2026 results: EPS: US$6.28 (down from US$7.05 in 1Q 2025). Revenue: US$97.8b (up 23% from 1Q 2025). Net income: US$784.0m (down 14% from 1Q 2025). Profit margin: 0.8% (down from 1.2% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Healthcare industry in Europe. Duyuru • Jul 30
Mckesson Corporation Declares Regular Dividend, Payable on October 1, 2025 The Board of Directors of McKesson Corporation declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025. Duyuru • Jun 26
McKesson Corporation to Report Q1, 2026 Results on Aug 06, 2025 McKesson Corporation announced that they will report Q1, 2026 results After-Market on Aug 06, 2025 Duyuru • Jun 23
McKesson Corporation, Annual General Meeting, Jul 30, 2025 McKesson Corporation, Annual General Meeting, Jul 30, 2025. Upcoming Dividend • May 23
Upcoming dividend of US$0.71 per share Eligible shareholders must have bought the stock before 30 May 2025. Payment date: 01 July 2025. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (5.5%). Lower than average of industry peers (2.3%). Reported Earnings • May 09
Full year 2025 earnings released: EPS: US$25.86 (vs US$22.54 in FY 2024) Full year 2025 results: EPS: US$25.86 (up from US$22.54 in FY 2024). Revenue: US$359.1b (up 16% from FY 2024). Net income: US$3.30b (up 9.8% from FY 2024). Profit margin: 0.9% (down from 1.0% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Healthcare industry in Europe. Duyuru • May 01
McKesson Corporation Declares Quarterly Dividend, Payable on July 1, 2025 The Board of Directors of McKesson Corporation declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on July 1, 2025, to stockholders of record on June 2, 2025. 
